MARÍA JOSÉ DEVESA MEDINA-rekin lankidetzan egindako argitalpenak (6)

2013

  1. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

    Annals of Hepatology, Vol. 12, Núm. 2, pp. 199-204

2012

  1. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  2. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

2010

  1. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

    Scandinavian Journal of Gastroenterology, Vol. 45, Núm. 1, pp. 51-59

2008

  1. "12 Weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: Two prognostic categories under the same label?

    Scandinavian Journal of Gastroenterology, Vol. 43, Núm. 8, pp. 979-983

2007

  1. Utilidad de la biopsia hepática en el diagnóstico etiológico de las alteraciones de la analítica hepática de causa incierta

    Gastroenterologia y Hepatologia, Vol. 30, Núm. 6, pp. 325-330